Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$42.05 - $47.77 $11,984 - $13,614
285 Added 49.65%
859 $37,000
Q4 2021

Feb 10, 2022

SELL
$38.88 - $45.31 $2,993 - $3,488
-77 Reduced 11.83%
574 $25,000
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $10,473 - $11,653
270 Added 70.87%
651 $25,000
Q2 2021

Aug 16, 2021

BUY
$36.52 - $41.46 $10,262 - $11,650
281 Added 281.0%
381 $15,000
Q4 2020

Feb 16, 2021

SELL
$34.07 - $39.94 $34,070 - $39,940
-1,000 Reduced 90.91%
100 $4,000
Q1 2018

May 07, 2018

BUY
$36.18 - $40.15 $36,180 - $40,150
1,000 Added 1000.0%
1,100 $43,000
Q4 2017

Feb 08, 2018

SELL
$35.34 - $41.9 $35,340 - $41,900
-1,000 Reduced 90.91%
100 $4,000
Q3 2017

Nov 09, 2017

BUY
$39.44 - $41.55 $43,384 - $45,705
1,100
1,100 $45,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.